Update! New CystoProtek Research Study Shows Long Term Effectiveness For Men and Women with IC/PBS. In the December 2008 issue of the Canadian Journal of Urology, Dr. Theoharides released the results of a new study that showed that
CystoProtek helped reduced the symptoms in IC patients with an average 50% effectiveness. Both men and women showed similar improvement levels and women with more severe symptoms showed a greater improvement.
Read it here!
- Download the CystoProtek brochure here
- CystoProtek Research Studies
- Read more about Cystoprotek ingredients
Algonot LLC originally developed Algonot Plus, CystoProtek and Prostaprotek. It's founder,
Dr. Theoharis Theoharides, has lectured on the Interstitial Cystitis Network three times. Read his three lectures below!